LEXICON PHARMACEUTICALS, INC. (LXRX) Share buybacks
- Total buybacks · last 12 months (USD): Value $1.73M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2024-12-31..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2024-12-31..
Share buybacks
Overview →Financial period ending 2024-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $1.73M | Trailing-year cash paid for share repurchases. Period ending 2024-12-31. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2024-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 1.73M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2024-12-31 | $1.73M | (m) | (m) |
| 2024-09-30 | $1.73M | (m) | (m) |
| 2024-06-30 | $1.73M | (m) | (m) |
| 2024-03-31 | $1.73M | (m) | (m) |
| 2023-12-31 | $824.00K | (m) | (m) |
| 2023-09-30 | $824.00K | (m) | (m) |
| 2023-06-30 | $824.00K | (m) | (m) |
| 2023-03-31 | $824.00K | (m) | (m) |
| 2022-12-31 | $864.00K | (m) | (m) |
| 2022-09-30 | $864.00K | (m) | (m) |
| 2022-06-30 | $864.00K | (m) | (m) |
| 2022-03-31 | $864.00K | (m) | (m) |
| 2021-12-31 | $2.67M | (m) | (m) |
| 2021-09-30 | $2.67M | (m) | (m) |
| 2021-06-30 | $2.67M | (m) | (m) |
| 2021-03-31 | $2.78M | (m) | (m) |
| 2020-12-31 | $1.03M | (m) | (m) |
| 2020-09-30 | $1.03M | (m) | (m) |
| 2020-06-30 | $1.03M | (m) | (m) |
| 2020-03-31 | $923.00K | (m) | (m) |
| 2019-12-31 | $941.00K | (m) | (m) |
| 2019-09-30 | $941.00K | (m) | (m) |
| 2019-06-30 | $941.00K | (m) | (m) |
| 2019-03-31 | $941.00K | (m) | (m) |
| 2018-12-31 | $972.00K | (m) | (m) |
| 2018-09-30 | $972.00K | (m) | (m) |
| 2018-06-30 | $972.00K | (m) | (m) |
| 2018-03-31 | $972.00K | (m) | (m) |
| 2017-12-31 | $1.68M | (m) | (m) |
| 2017-09-30 | $1.68M | (m) | (m) |
| 2017-06-30 | $1.68M | (m) | (m) |
| 2017-03-31 | $1.68M | (m) | (m) |
| 2016-12-31 | $621.00K | (m) | (m) |
| 2016-09-30 | $621.00K | (m) | (m) |
| 2016-06-30 | $621.00K | (m) | (m) |
| 2016-03-31 | $621.00K | (m) | (m) |
| 2015-12-31 | $357.00K | (m) | (m) |
| 2015-09-30 | $357.00K | (m) | (m) |
| 2015-06-30 | $357.00K | (m) | (m) |
| 2015-03-31 | $357.00K | (m) | (m) |
| 2014-12-31 | $887.00K | (m) | (m) |
| 2014-09-30 | $887.00K | (m) | (m) |
| 2014-06-30 | $887.00K | (m) | (m) |
| 2014-03-31 | $887.00K | (m) | (m) |
| 2013-12-31 | $873.00K | (m) | (m) |
| 2013-09-30 | $873.00K | (m) | (m) |
| 2013-06-30 | $873.00K | (m) | (m) |
| 2013-03-31 | $873.00K | (m) | (m) |
| 2012-12-31 | $285.00K | (m) | (m) |
| 2012-09-30 | $285.00K | (m) | (m) |
| 2012-06-30 | $285.00K | (m) | (m) |
| 2012-03-31 | $285.00K | (m) | (m) |
| 2011-12-31 | $108.00K | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | $149.00K | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | $88.00K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |